From Germline Genetics to Function: Making Sense of Genome-Wide Association Studies for Pancreatic Cancer Risk
NIH Directors Seminar Series
Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related deaths in the United States and the seventh world-wide. This seminar will discuss results from genome-wide association studies (GWAS), conducted within the NCI-led Pancreatic Cancer Cohort Consortium. This collaborative effort has identified over 20 common pancreatic cancer risk loci. Genomic and functional characterization of a subset of these loci will be presented. These examples highlight different molecular mechanisms underlying cancer risk and genes found to be important for a wide range of processes incl...
Source: Videocast - All Events - March 1, 2018 Category: General Medicine Tags: Upcoming Events Source Type: video
Oncogene Addiction
NCI Center for Cancer Research Eminent Lecture
Dr. Felsher obtained a B.A. in Chemistry at the University of Chicago, a M.D. Ph.D. from the University of California, Los Angeles School of Medicine. He performed his graduate work in Molecular Biology/Immunology under Dr. Jonathan Braun. He trained in Internal Medicine at the Hospital of the University of Pennsylvania and Oncology at the University of California, San Francisco and his post-doctoral research under Dr. J. Michael Bishop. Dr. Felsher has been faculty at Stanford University for 16 years and performing both basic and translational cancer research and is the foun...
Source: Videocast - All Events - May 18, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Why do most patients with epithelial cancers not respond to T cell checkpoint blockade?
NCI Center for Cancer Research Eminent Lecture
Over the past 40 years, Dr. Fearon has made contributions to our understanding of innate immunity, B cell signal transduction, memory T cells, and, most recently, cancer immunology. During the past 10 years, Dr. Fearon has trained 15 PhD and MB/PhD students at the University of Cambridge. Former post-doctoral fellows now have faculty or staff positions at outstanding institutions such as Harvard Medical School, the NIAID, University of Cambridge, King’s College London, University of Leicester, and the University of Ryukyus. His past work with a genetically engineered mous...
Source: Videocast - All Events - April 20, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Protein Phosphorylation and Cell Signaling in Cancer
NCI Center for Cancer Research Eminent Lecture
Tony Hunter is the Renato Dulbecco Chair in Cancer Research, Director of the Salk Institute Cancer Center and an American Cancer Society Professor in the Molecular and Cell Biology Laboratory at the Salk Institute for Biological Studies in La Jolla. In 1979, through his work on tumor viruses, he discovered a new class of protein kinase that phosphorylates tyrosine. He has spent most of the last 35 years studying protein kinases and phosphatase, and the role of protein phosphorylation in cell proliferation and the cell cycle, and how aberrant protein phosphorylation can caus...
Source: Videocast - All Events - February 17, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Margaret A. Tempero, MD - Community-Expert Conversations in Pancreatic Adenocarcinoma: New Therapies and Novel Concepts for Daily Practice
Community-Expert Conversations in Pancreatic Adenocarcinoma: New Therapies and Novel Concepts for Daily Practice (Source: PeerView CME/CE Video Podcast - Oncology)
Source: PeerView CME/CE Video Podcast - Oncology - July 3, 2014 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video
Margaret A. Tempero, MD - New Hope in Pancreatic Adenocarcinoma: Bringing Innovative Therapy to Clinical Practice
New Hope in Pancreatic Adenocarcinoma: Bringing Innovative Therapy to Clinical Practice (Source: Peerview CME/CE Video Podcast - Internal Medicine International)
Source: Peerview CME/CE Video Podcast - Internal Medicine International - February 18, 2014 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video
Axel Grothey, MD - Molecular Targets and New Therapies in Gastric Adenocarcinoma: Are We Moving Towards Individualized Management and Improved Outcomes?
(Source: PeerView CME/CE Video Podcast - Oncology)
Source: PeerView CME/CE Video Podcast - Oncology - October 10, 2013 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video
Endoscopic submucosal dissection of a well-differentiated intestinal type intramucosal gastric adenocarcinoma
Sergio Coda, MD, PhD, Imperial College London, UK Paolo Trentino, MD, University of Rome This video demonstrates the ESD technique used to remove a type 0-IIa+IIc 15 mm early gastric cancer of the fundus in a 79 year-old male patient. The procedure took place in the operating theatre, under deep sedation, with back-up surgical team available. Preoperative endoscopy included contrast chromoscopy with 0.2% indigo carmine dye together w [...] (Source: The Digital Atlas of Video Education - Gastroenterology)
Source: The Digital Atlas of Video Education - Gastroenterology - January 22, 2013 Category: Gastroenterology Authors: admin Tags: Stomach Source Type: video
